KWM
NXL icon

Kingsview Wealth Management’s Nexalin Technology NXL Stock Holding History

Kingsview Wealth Management’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$9.17K – 1304
2025
Q3 		$9.17K Hold
10,000
– – ﹤0.01% 1193
2025
Q2 		$9.88K Hold
10,000
– – ﹤0.01% 1161
2025
Q1 		$19.5K Hold
10,000
– – ﹤0.01% 1082
2024
Q4 		$27.6K Buy
+10,000
New +$27.8K ﹤0.01% 1096

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Kingsview Wealth Management's NXL Position: Q4 2025 in Review

Kingsview Wealth Management sold out of Nexalin Technology (NXL) in Q4 2025, closing a stake of 10,000 shares — an estimated $9.17K sold.

Kingsview Wealth Management first reported a position in NXL in Q4 2024 and held it in 4 quarters. The position peaked at $27.6K in Q4 2024. 19 funds tracked by Wall St. Rank hold NXL as of Q4 2025.

  • Kingsview Wealth Management reported no remaining Nexalin Technology position as of Q4 2025 after selling out during the quarter.
  • Kingsview Wealth Management sold 10,000 Nexalin Technology shares in Q4 2025, an estimated $9.17K.
  • Kingsview Wealth Management first reported a position in Nexalin Technology in Q4 2024 and held it in 4 quarters.
  • Kingsview Wealth Management's Nexalin Technology position peaked at $27.6K in Q4 2024.
  • 19 funds tracked by Wall St. Rank held Nexalin Technology as of Q4 2025.

Based on Kingsview Wealth Management's 13F filing for Q4 2025, filed 9 Feb 2026.